Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.

Saved in:
Bibliographic Details
Title: Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
Authors: Shih BB; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ma C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Cortes JR; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Miller H; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Albero R; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain., Laurent AP; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Mackey A; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA., Geskin L; Department of Medicine, Columbia University Medical Center, New York, New York, USA., Palomero T; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu.
Source: The Journal of investigative dermatology [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1579-1589.e8. Date of Electronic Publication: 2024 Jan 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38219917
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shih+BB%22">Shih BB</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ma+C%22">Ma C</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cortes+JR%22">Cortes JR</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Reglero+C%22">Reglero C</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Miller+H%22">Miller H</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Quinn+SA%22">Quinn SA</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Albero+R%22">Albero R</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Laurent+AP%22">Laurent AP</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mackey+A%22">Mackey A</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ferrando+AA%22">Ferrando AA</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Geskin+L%22">Geskin L</searchLink>; Department of Medicine, Columbia University Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Palomero+T%22">Palomero T</searchLink>; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220426720%22">The Journal of investigative dermatology</searchLink> [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1579-1589.e8. <i>Date of Electronic Publication: </i>2024 Jan 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0426720 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-1747 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022202X%22">0022202X </searchLink><i>NLM ISO Abbreviation: </i>J Invest Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38219917
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jid.2023.12.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1579
    Titles:
      – TitleFull: Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shih BB
      – PersonEntity:
          Name:
            NameFull: Ma C
      – PersonEntity:
          Name:
            NameFull: Cortes JR
      – PersonEntity:
          Name:
            NameFull: Reglero C
      – PersonEntity:
          Name:
            NameFull: Miller H
      – PersonEntity:
          Name:
            NameFull: Quinn SA
      – PersonEntity:
          Name:
            NameFull: Albero R
      – PersonEntity:
          Name:
            NameFull: Laurent AP
      – PersonEntity:
          Name:
            NameFull: Mackey A
      – PersonEntity:
          Name:
            NameFull: Ferrando AA
      – PersonEntity:
          Name:
            NameFull: Geskin L
      – PersonEntity:
          Name:
            NameFull: Palomero T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1523-1747
          Numbering:
            – Type: volume
              Value: 144
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The Journal of investigative dermatology
              Type: main
ResultId 1